EHMT2 and Alzheimer disease: Of clinical significance, this cross-species proteomic comparison validated the mouse-to-human conserved, G9a-translation mechanism of MS1262 reversal of AD-correlated pathways; this mouse-to-human correlation strongly suggests that MS1262 inhibition of G9a would be an effective therapy for AD patients.